These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 35110406)
41. Identification of isoform/domain-selective fragments from the selection of DNA-encoded dynamic library. Zhou Y; Shen W; Peng J; Deng Y; Li X Bioorg Med Chem; 2021 Sep; 45():116328. PubMed ID: 34364223 [TBL] [Abstract][Full Text] [Related]
42. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer. Wang J; Song C; Tang H; Zhang C; Tang J; Li X; Chen B; Xie X Breast Cancer Res; 2017 Jun; 19(1):72. PubMed ID: 28629464 [TBL] [Abstract][Full Text] [Related]
43. Discovery of potent thrombin inhibitors from a protease-focused DNA-encoded chemical library. Dawadi S; Simmons N; Miklossy G; Bohren KM; Faver JC; Ucisik MN; Nyshadham P; Yu Z; Matzuk MM Proc Natl Acad Sci U S A; 2020 Jul; 117(29):16782-16789. PubMed ID: 32641511 [TBL] [Abstract][Full Text] [Related]
44. MicroRNA-145 functions as a tumor suppressor by targeting matrix metalloproteinase 11 and Rab GTPase family 27a in triple-negative breast cancer. Tang L; Wei D; Yan F Cancer Gene Ther; 2016 Aug; 23(8):258-65. PubMed ID: 27364572 [TBL] [Abstract][Full Text] [Related]
45. Rational Design of Small Molecules Targeting Oncogenic Noncoding RNAs from Sequence. Disney MD; Angelbello AJ Acc Chem Res; 2016 Dec; 49(12):2698-2704. PubMed ID: 27993012 [TBL] [Abstract][Full Text] [Related]
46. DNA-encoded libraries - an efficient small molecule discovery technology for the biomedical sciences. Kunig V; Potowski M; Gohla A; Brunschweiger A Biol Chem; 2018 Jun; 399(7):691-710. PubMed ID: 29894294 [TBL] [Abstract][Full Text] [Related]
47. Emerging role of microRNA-27a in human malignant glioma cell survival via targeting of prohibitin. Chen W; Qi J; Bao G; Wang T; Du CW; Wang MD Mol Med Rep; 2015 Jul; 12(1):1515-23. PubMed ID: 25777779 [TBL] [Abstract][Full Text] [Related]
48. Circular RNA circ-ZEB1 acts as an oncogene in triple negative breast cancer via sponging miR-448. Pei X; Zhang Y; Wang X; Xue B; Sun M; Li H Int J Biochem Cell Biol; 2020 Sep; 126():105798. PubMed ID: 32629026 [TBL] [Abstract][Full Text] [Related]
49. Lentiviral expression of anti-microRNAs targeting miR-27a inhibits proliferation and invasiveness of U87 glioma cells. Feng SY; Dong CG; Wu WK; Wang XJ; Qiao J; Shao JF Mol Med Rep; 2012 Aug; 6(2):275-81. PubMed ID: 22614734 [TBL] [Abstract][Full Text] [Related]
50. Capn4 expression is modulated by microRNA-520b and exerts an oncogenic role in prostate cancer cells by promoting Wnt/β-catenin signaling. Ren W; Wang D; Li C; Shu T; Zhang W; Fu X Biomed Pharmacother; 2018 Dec; 108():467-475. PubMed ID: 30241050 [TBL] [Abstract][Full Text] [Related]
51. Profiling cells with DELs: Small molecule fingerprinting of cell surfaces. Deng J; Belyanskaya S; Prabhu N; Arico-Muendel C; Deng H; Phelps CB; Israel DI; Yang H; Boyer J; Franklin GJ; Yap JL; Lind KE; Tsai CH; Donahue C; Summerfield JD SLAS Discov; 2024 Jul; 29(5):100171. PubMed ID: 38917882 [TBL] [Abstract][Full Text] [Related]
52. Low abundance of TFPI-2 by both promoter methylation and miR-27a-3p regulation is linked with poor clinical outcome in gastric cancer. Geng G; Liu X; Xu A; Lu Z; Chen K; He J; Qi D; Yuan X J Gene Med; 2020 May; 22(5):e3166. PubMed ID: 31984574 [TBL] [Abstract][Full Text] [Related]
53. miR-27a regulates the sensitivity of breast cancer cells to cisplatin treatment via BAK-SMAC/DIABLO-XIAP axis. Zhou S; Huang Q; Zheng S; Lin K; You J; Zhang X Tumour Biol; 2016 May; 37(5):6837-45. PubMed ID: 26662313 [TBL] [Abstract][Full Text] [Related]
54. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression. Guo GC; Wang JX; Han ML; Zhang LP; Li L Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302 [TBL] [Abstract][Full Text] [Related]
55. MicroRNA-137 Inhibits Cancer Progression by Targeting Del-1 in Triple-Negative Breast Cancer Cells. Lee SJ; Jeong JH; Kang SH; Kang J; Kim EA; Lee J; Jung JH; Park HY; Chae YS Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817673 [TBL] [Abstract][Full Text] [Related]
56. miR-365 inhibits cell invasion and migration of triple negative breast cancer through ADAM10. Liu F; Zhuang L; Wu R; Li D J BUON; 2019; 24(5):1905-1912. PubMed ID: 31786854 [TBL] [Abstract][Full Text] [Related]
57. Selection Method of DNA-Encoded Chemical Library for Irreversible Covalent Binders. Zhu Z Methods Mol Biol; 2022; 2541():165-172. PubMed ID: 36083555 [TBL] [Abstract][Full Text] [Related]
58. The stromal loss of miR-4516 promotes the FOSL1-dependent proliferation and malignancy of triple negative breast cancer. Kim JE; Kim BG; Jang Y; Kang S; Lee JH; Cho NH Cancer Lett; 2020 Jan; 469():256-265. PubMed ID: 31672492 [TBL] [Abstract][Full Text] [Related]
59. Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer. Mekala JR; Naushad SM; Ponnusamy L; Arivazhagan G; Sakthiprasad V; Pal-Bhadra M Gene; 2018 Jan; 641():248-258. PubMed ID: 29038000 [TBL] [Abstract][Full Text] [Related]